{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:16:53Z","timestamp":1789082213683,"version":"build-2803163510"},"reference-count":67,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01133","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T04:26:01Z","timestamp":1505276761000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1\u2013T146"],"prefix":"10.3389","volume":"8","author":[{"given":"Alessandra","family":"Consonni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lebrero-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Yngve","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Baggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bcp.2015.07.011","article-title":"AChR-specific immunosuppressive therapy of myasthenia gravis","volume":"97","author":"Luo","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/08916934.2011.611550","article-title":"T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients","volume":"45","author":"Oshima","year":"2012","journal-title":"Autoimmunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1586\/1744666X.2015.1047345","article-title":"The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics","volume":"11","author":"Alahgholi-Hajibehzad","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J Autoimmun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clim.2017.03.003","article-title":"CD4 + FoxP3 + T regulatory cell subsets in myasthenia gravis patients","volume":"179","author":"Kohler","year":"2017","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4+CD25highCD127low\/\u2212 T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2015.09.005","article-title":"Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells","volume":"67","author":"Aricha","year":"2016","journal-title":"J Autoimmun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mcn.2013.03.005","article-title":"Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1\/Th17 to Th2 cytokines","volume":"56","author":"Li","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jneuroim.2016.07.016","article-title":"Astilbin ameliorates experimental autoimmune myasthenia gravis by decreased Th17 cytokines and up-regulated T regulatory cells","volume":"298","author":"Meng","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4 + T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.expneurol.2009.09.022","article-title":"T-bet deficiency decreases susceptibility to experimental myasthenia gravis","volume":"220","author":"Liu","year":"2009","journal-title":"Exp Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nm.2625","article-title":"Optimization of current and future therapy for autoimmune diseases","volume":"18","author":"Steinman","year":"2012","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1517\/21678707.2013.779920","article-title":"Orphan drugs to treat myasthenia gravis","volume":"1","author":"Maggi","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/507418a","article-title":"Immunology: a tolerant approach","volume":"507","author":"Garber","year":"2014","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2249.1998.00521.x","article-title":"Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals","volume":"111","author":"Shi","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2016.12.011","article-title":"Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains","volume":"303","author":"Lazaridis","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2015.02.009","article-title":"Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization","volume":"270","author":"Tuzun","year":"2014","journal-title":"Exp Neurol"},{"key":"B22","first-page":"73","article-title":"Regulatory T cell-based therapies for autoimmunity","volume":"22","author":"Arellano","year":"2016","journal-title":"Discov Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1212\/WNL.0b013e3182050599","article-title":"Improving long-term follow-up studies of immunomodulatory therapies","volume":"76","author":"Freedman","year":"2011","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"ra75","DOI":"10.1126\/scitranslmed.3006168","article-title":"Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/art.24566","article-title":"Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis","volume":"60","author":"Hasselberg","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/pbi.12479","article-title":"Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis","volume":"14","author":"Hansson","year":"2016","journal-title":"Plant Biotechnol J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fimmu.2016.00355","article-title":"Tr1-like T cells \u2013 an enigmatic regulatory T cell lineage","volume":"7","author":"White","year":"2016","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1172\/JCI7121","article-title":"Oral administration of an immunodominant T-cell epitope downregulates Th1\/Th2 cytokines and prevents experimental myasthenia gravis","volume":"104","author":"Baggi","year":"1999","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.146.9.2977","article-title":"Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes","volume":"146","author":"Infante","year":"1991","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.4049\/jimmunol.170.3.1240","article-title":"Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo","volume":"170","author":"Sundstedt","year":"2003","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/IJGM.S88552","article-title":"Animal models of myasthenia gravis: utility and limitations","volume":"9","author":"Mantegazza","year":"2016","journal-title":"Int J Gen Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-662-43492-5_3","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.410360504","article-title":"Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis","volume":"36","author":"Okumura","year":"1994","journal-title":"Ann Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0165-5728(94)00187-S","article-title":"Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor","volume":"58","author":"Ma","year":"1995","journal-title":"J Neuroimmunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1073\/pnas.96.14.8086","article-title":"Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit","volume":"96","author":"Barchan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0165-5728(00)00395-7","article-title":"Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis","volume":"111","author":"Im","year":"2000","journal-title":"J Neuroimmunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1073\/pnas.89.13.5852","article-title":"Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide","volume":"89","author":"Atassi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1172\/JCI119857","article-title":"Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences","volume":"100","author":"Karachunski","year":"1997","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.addr.2017.04.005","article-title":"In vivo reprogramming of immune cells: technologies for induction of antigen-specific tolerance","volume":"114","author":"Pearson","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1073\/pnas.96.26.15056","article-title":"Extracellular antigen processing and presentation by immature dendritic cells","volume":"96","author":"Santambrogio","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1212\/NXI.0000000000000093","article-title":"Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS","volume":"2","author":"Streeter","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/ncomms5741","article-title":"Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy","volume":"5","author":"Burton","year":"2014","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/mi.2011.61","article-title":"Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses","volume":"5","author":"Semmrich","year":"2012","journal-title":"Mucosal Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00281-016-0587-8","article-title":"Tolerogenic dendritic cells","volume":"39","author":"Takenaka","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/J.1749-6632.1998.TB10910.X","article-title":"Molecular and antigenic structure of nicotinic acetylcholine receptors","volume":"841","author":"Lindstrom","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.autrev.2013.03.006","article-title":"Novel future therapeutic options in myasthenia gravis","volume":"12","author":"Dalakas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J Neurosci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molimm.2008.08.264","article-title":"Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor","volume":"46","author":"Yi","year":"2008","journal-title":"Mol Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/08916930600738581","article-title":"Subtle differences in HLA DQ haplotype-associated presentation of AChR \u03b1-chain peptides may suffice to mediate myasthenia gravis","volume":"39","author":"Deitiker","year":"2006","journal-title":"Autoimmunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"F5","DOI":"10.1084\/jem.193.2.F5","article-title":"Differentiation of T regulatory cells by immature dendritic cells","volume":"193","author":"Roncarolo","year":"2001","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0008-8749(03)00118-7","article-title":"Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells","volume":"223","author":"Xiao","year":"2003","journal-title":"Cell Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nbd.2004.03.017","article-title":"Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells","volume":"16","author":"Duan","year":"2004","journal-title":"Neurobiol Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1365-2249.2002.01748.x","article-title":"Dendritic cells exposed in vitro to TGF-\u03b21 ameliorate experimental autoimmune myasthenia gravis","volume":"127","author":"Yarilin","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1073\/pnas.0906872106","article-title":"CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2","volume":"106","author":"Okamura","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.4049\/jimmunol.1100530","article-title":"Segregated regulatory CD39+CD4+ T cell function: TGF-\u03b2-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis","volume":"187","author":"Kochetkova","year":"2011","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ni1541","article-title":"A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells","volume":"8","author":"Awasthi","year":"2007","journal-title":"Nat Immunol"},{"key":"B62","volume-title":"Statistical Methods","author":"Snedecor","year":"1989"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1016\/S0165-2478(97)88001-7","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4049\/jimmunol.151.2.1025","article-title":"Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells","volume":"151","author":"Bellone","year":"1993","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1042\/bj1850667","article-title":"Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins","volume":"185","author":"Elliott","year":"1980","journal-title":"Biochem J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/0076-6879(81)74031-X","article-title":"Production and assay of antibodies to acetylcholine receptors","volume":"74","author":"Lindstrom","year":"1981","journal-title":"Methods Enzymol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T19:23:31Z","timestamp":1692991411000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,13]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2017.01133"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01133","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,13]]},"article-number":"1133"}}